Related by context. All words. (Click for frequent words.) 83 miRview ™ mets 78 miRview TM squamous 78 miRview ™ meso 73 Cervista HPV HR 72 miRview TM mets 72 miRview squamous 71 miRview meso 70 eTag assays 70 miRview mets 69 VeriStrat 69 differentiate squamous 69 Azedra 69 Oncotype DX colon cancer 68 miRview ® 68 Mammostrat 68 Septin 9 68 immunochemical 68 MammaPrint R 68 PROLARIS 68 Epigenomics proprietary 67 xTAG Cystic Fibrosis 67 Corus CAD 67 immunohistochemistry IHC 67 miRview TM meso 67 metastatic neuroendocrine tumors 67 PGxPredict 67 Septin9 67 multigene expression test 67 p# biomarker 66 NMP# 66 Alternans 66 NADiA 66 molecular diagnostic assay 66 DNA methylation biomarkers 66 APTIMA HPV 66 MAGE A3 ASCI 66 GeneSightRx 65 immunohistochemical analysis 65 Kit v2 65 GAMMAGARD 65 LungAlert TM 65 VerifyNow P#Y# 65 Agilent microarrays 65 radiolabeled TM# 65 ZOLINZA 65 Tr DNA 65 Trofex 65 FDG-PET/CT 65 NSCLC tumors 65 Squamous 65 MTWA testing 65 ChemoFx 65 miRview ™ 65 qualitative serum 65 nonsmall cell lung cancer 65 multiplexed assays 65 transcriptional profiling 65 immunohistochemical 64 mSEPT9 64 Genetic Analyzer 64 Gliadel Wafer 64 chimeric monoclonal antibody 64 co receptor tropism 64 CellSearch System 64 FullTerm 64 HepDirect prodrug 64 ImmuKnow R 64 Alfacell proprietary ribonuclease 64 gefitinib Iressa 64 assay detects 64 Oncotype DX breast cancer 64 Haptoglobin 64 EUS FNA 64 busulfan 64 CellSearch ™ 64 OnDose 64 Neulasta R 64 genetic biomarkers 64 vitro assay 64 tumor specific antigen 64 preclinical efficacy 64 bDNA 64 ResponseDX Lung TM 64 cleavable linker 64 ImmuKnow 64 PSMA ADC 64 Trofile assay 64 squamous miRview ™ mets 64 SPECT CT imaging 64 delafloxacin 64 microRNA profiling 64 histone deacetylase HDAC inhibitor 64 immunohistochemical staining 64 multiplex PCR 64 VeraTag 64 microRNA biomarkers 64 epithelial tumors 64 Her2/neu 64 Src inhibitors 64 guaiac 64 kidney urologic 63 UroVysion 63 proteomic biomarkers 63 fosbretabulin 63 nCounter Analysis System 63 deCODE AF TM 63 Anticalins ® 63 KRAS mutation 63 miRNA biomarkers 63 miRview TM 63 Azedra ™ 63 xMAP Technology 63 WavSTAT 63 PCA3 63 murine models 63 anti CD# antibodies 63 molecular diagnostic assays 63 index assay IVDMIA 63 ProteinChip 63 biomarker assay 63 AlloMap 63 methylation markers 63 histone deacetylase inhibitor 63 trastuzumab DM1 T DM1 63 LungSign TM 63 ENMD # 63 nanopharmaceutical 63 liposomal formulation 63 Epi proColon 63 T#I [002] 63 recurrent NSCLC 63 NMP# BladderChek Test 63 nested PCR 63 DNA methylation markers 63 Xanafide 63 LungExpress Dx 63 BladderChek 63 PreGen Plus 63 HE4 test 63 Zolinza 63 relapsed MM 63 BrachySil TM 63 molecular biomarkers 63 situ hybridization 63 Radient Pharmaceutical current 63 NMR LipoProfile test 63 KRAS mutations occur 63 metastatic colorectal 63 Optical Biopsy System 63 targeted radiotherapeutic 63 ResponseDX Colon TM 63 percutaneous biopsy 63 OncoVex 63 NPM1 63 transfection reagents 63 Doripenem 63 HPV genotyping 63 Western Blotting 63 MGd 63 bisulfite sequencing 63 K ras mutations 63 erlotinib Tarceva ® 63 CTAP# Capsules 63 NuroPro PD 62 brivanib 62 QuadraSphere 62 FDG PET imaging 62 Locked Nucleic Acid LNA 62 Cologuard 62 stable nucleic acid 62 Cervista HPV 62 CINtec ® PLUS 62 RT qPCR 62 diagnostic biomarker 62 Cardiolite ® 62 genomic profiling 62 HepaMate 62 epoetin alpha 62 HER2 expression 62 RECAF TM 62 Pertuzumab 62 OVA1 62 Oncotype 62 lexidronam injection 62 HE4 62 AtherOx 62 synthetic retinoid 62 humanized monoclonal antibodies 62 IDI MRSA 62 BRACAnalysis ® 62 OncotypeDX 62 YONDELIS 62 CIN2 + 62 kinase profiling 62 transcranial Doppler ultrasound 62 KRAS mutations 62 vitespen 62 HTS assay 62 florbetaben 62 acid phosphatase PAP 62 miRNA profiling 62 ESBA# 62 Oncotype DX ® 62 urine cytology 62 pan HDAC inhibitor 62 refractory chronic lymphocytic 62 Surface Plasmon Resonance SPR 62 nucleic acid amplification 62 QPCR 62 intravesical infusion therapy 62 SensiGene 62 evaluating tivozanib 62 CINtec R 62 Zysolin TM 62 SIR Spheres 62 Naive Patients 62 EarlyCDT Lung 62 metabolomic profiling 62 therapeutic radiopharmaceuticals 62 ocular formulation 62 tests miRview TM 62 antibody arrays 62 HemeScan 62 PLAC test 62 OvaDx 62 #F FDG 62 recurrent glioblastoma multiforme 62 Epidermal Growth Factor Receptor 62 VeraCode 62 Screening Trial 62 Granisetron 62 Preclinical Study 62 antagomirs 62 tumor xenograft models 62 enzyme immunoassay EIA 62 drug zotarolimus 62 mda 7 62 COR Analyzer 62 ELISpot 62 tumor biopsies 62 EDEMA3 62 radezolid 62 FFR measurements 62 pancreatic adenocarcinoma 62 Oral NKTR 62 Fludara ® 62 flavopiridol 62 Aflibercept 62 trabectedin 62 ZACTIMA 62 multiplex assay 62 DNA methylation biomarker 62 replicon 62 multicenter clinical trials 62 CA9 SCAN 62 tubulin inhibitor 62 multi analyte 62 bactericidal activity 62 sorafenib tablets 62 myelofibrosis polycythemia vera 62 monoclonal antibody conjugated 62 prostate carcinoma 62 automated microscopy 62 VerifyNow 62 engineered RAP peptides 62 Cepheid GeneXpert 62 MAGE A3 61 xCELLigence System 61 multiplex assays 61 reaction RT PCR 61 tumor subtypes 61 cediranib 61 UGT#A# 61 Registry NOPR 61 histological subtype 61 Spartan RX CYP#C# 61 Solazed 61 Mass Spectrometry MS 61 Intravesical 61 DNAwithPap TM Test 61 CyPath ® 61 sputum specimens 61 PROMUS Element Stent 61 sorafenib Nexavar 61 Xcellerated T Cells 61 Rosetta Genomics microRNA 61 Avise PG 61 comparative genomic hybridization 61 histologic diagnosis 61 underwent surgical resection 61 endocrine therapies 61 immunofluorescence staining 61 Breast Cancer Assay 61 Temsirolimus 61 trastuzumab emtansine T DM1 61 transrectal ultrasound guided 61 Electronic Brachytherapy 61 multiparametric 61 MammaPrint 61 mertansine 61 aCGH 61 Eluting Coronary Stent System 61 ToGA 61 SilverHawk Plaque Excision System 61 Flow cytometry 61 quantitative gene expression 61 systemic RNAi therapeutic 61 muco adhesive technology 61 BACcel 61 Cerashield 61 rxRNA 61 hypermethylated 61 EOquin TM 61 therapeutic monoclonal antibody 61 Affymetrix microarray technology 61 Deforolimus 61 selective kinase inhibitor 61 PCR assay 61 RQ PCR 61 Tem PCR 61 small molecule activators 61 FAMILION 61 topically applied SEPA 61 reagent kits 61 untreated metastatic melanoma 61 microarray experiments 61 CIMZIA TM certolizumab pegol 61 Gleevec resistant 61 Phase #b/#a clinical 61 Digital Mammographic Imaging 61 oligonucleotide arrays 61 DNA Methylation 61 K RAS 61 hypervascular tumors 61 papillary renal cell carcinoma 61 multicenter Phase II 61 vinca alkaloid 61 Digene HPV Test 61 tissue microarrays 61 docetaxel Taxotere ® 61 BRAF V#E mutation 61 SELDI TOF MS 61 Telatinib 61 galiximab 61 TriGrid 61 Capsule endoscopy 61 DiLA2 61 PHX# 61 fluoropyrimidine 61 xTAG RVP 61 PrevOnco 61 hybridoma 61 pain palliation 61 Achieves Primary Endpoint 61 CellPort Technologies 61 VERSANT 61 Immunotherapeutic 61 OncoVEX 61 cardiac troponin T 61 HERmark 61 visit www.genenews.com 61 AttoSense 61 PCA3 gene 61 Bezielle 61 ALN HPN 61 Solazed TM 61 gene expression assays 61 ABLAVAR ™ 61 Optical coherence tomography 61 BSGI MBI 61 Affymetrix GeneChip ® 61 CLIA laboratory 61 Daptomycin 61 HQK 61 HDA GT# TM 61 CYT# potent vascular disrupting 61 metaglidasen 61 gemcitabine carboplatin 61 T SPOT.TB 61 Squalamine 61 unresectable tumors 61 PEGylated interferon 61 antiangiogenic activity 61 Carfilzomib 61 PITX2 61 prognostic biomarker 61 Seeplex 61 ChIP chip 61 CyPath 61 Alexza Staccato 61 gastric adenocarcinoma 61 radiation dosimetry 61 Rilonacept 61 vivo fluorescence imaging 61 NicAlert TM 61 Multimeric 61 Nucleic Acid Detection Immunoassay 61 PDX pralatrexate 61 Gemzar ® 61 Regenerative Cells 61 FISH fluorescence 61 BCR ABL mutations 61 Onalta TM 61 uricase 61 Cx# [002] 61 NMP# BladderChek 61 Gene Expression Assays 61 transabdominal 61 phenotyping 61 Myocet 61 Initiate Clinical Trial 61 Xpert C. difficile 61 CCX# 61 Septin9 biomarker 61 antiangiogenic agent 61 diagnostic modality 61 situ hybridization FISH 61 EGFr expressing metastatic colorectal 61 ARCHITECT HIV 61 S. maltophilia 61 Human Leukocyte Antigen 61 SiMoA 61 Abbott ARCHITECT 61 LEUKINE 61 reagent kit 61 cisplatin resistant 61 Applied Biosystems TaqMan 61 metastatic malignant 61 SELDI 61 AdnaTest 61 XIENCE V Everolimus Eluting 61 multicenter multinational 61 microtubule inhibitor 61 malignant ascites 61 optical coherence tomography OCT 61 nucleotide analog 61 RECIST Response Evaluation Criteria 61 Hemopurifier 60 RECOTHROM R 60 NMP# assay 60 whole genome genotyping 60 cytotoxicity assays 60 GORE TAG Device 60 transcriptome sequencing 60 HTRF R 60 delipidation 60 vincristine doxorubicin 60 Septin 9 biomarker 60 ThinPrep Pap Test 60 VKORC1 60 Hepatocellular Carcinoma HCC 60 PD2i ® nonlinear algorithm 60 diagnostic prognostic 60 Ibis T# 60 Infinium assay 60 Accelerated Partial Breast Irradiation 60 huN# DM1 60 Anticalins R 60 Immunohistochemistry 60 OvaRex MAb 60 enzyme immunoassay 60 bladder ovarian 60 amplified nucleic acid 60 human IgG1 monoclonal 60 PathFinderTG 60 JAK inhibitor 60 OnDose TM 60 fluvastatin 60 sDNA 60 gene expression profiling 60 p# biomarkers 60 COLARIS 60 biologic pathway 60 nucleic acid molecules 60 PreDx 60 pathologic examination 60 ADVIA Centaur 60 Onconase 60 sd rxRNA 60 Omacetaxine 60 HyACT 60 KineMarker TM 60 Surgical resection 60 SQiDworks 60 genotyping assay 60 microarray analysis 60 histological subtypes 60 mutational analysis 60 Neoadjuvant chemotherapy 60 peptide antigens 60 Viatronix V3D Colon 60 NEUGENE 60 GORE EXCLUDER AAA Endoprosthesis 60 Gamma Imaging BSGI 60 Dacogen decitabine 60 quantitative RT PCR 60 cell lysate 60 Illumina Infinium 60 Thrombin 60 qRT PCR 60 candidates Azedra TM 60 ASCUS 60 nucleotide analogue 60 Affibody ® molecules 60 intravesical instillation 60 Litx 60 Perforomist ™ Inhalation Solution 60 Retisert 60 Optical Coherence Tomography 60 Immunohistochemical staining 60 TM PCA3 60 stent DES 60 Albuferon TM 60 gene methylation 60 HGS ETR1 mapatumumab 60 NMP# R 60 Tumor Response 60 clinically localized prostate 60 formalin fixed paraffin embedded 60 prospective multicenter study 60 HER2 overexpression 60 Trastuzumab DM1 60 XmAb# 60 Comparative Genomic Hybridization 60 doxorubicin Transdrug ® 60 Altera Nebulizer System 60 MTWA 60 dimeglumine 60 fidaxomicin Phase 3 60 microarray gene expression 60 opto acoustic 60 AGHD 60 Curaxin CBLC# 60 relapsing remitting MS RRMS 60 Xpert MRSA 60 Alferon LDO 60 HIFU therapy 60 trial evaluating PRX# 60 Tyrima 60 DEEP AF 60 LNA TM 60 receptor tyrosine kinase inhibitor 60 antisense inhibitors 60 Single Nucleotide Polymorphism SNP 60 LHRH receptor positive 60 intraoperative ultrasound 60 abacavir Ziagen 60 HER1 60 OMP #M# 60 HCV protease inhibitor 60 pharmacogenomic tests 60 BACcel ™ 60 malignant nodules 60 benign neoplasms 60 Lp PLA 2 60 Papillary 60 Xelox 60 Roche AmpliChip 60 Aliskiren 60 humanised antibody 60 AviaraDx 60 ResponseDX ™ 60 FDG PET 60 preoperative staging 60 hA# 60 cellular immunotherapy 60 orally administered inhibitor 60 topical gel containing 60 VitiGam 60 Screening Trial DMIST 60 Soliris eculizumab 60 tumors GIST 60 clinically validated 60 favorable pharmacokinetic profile 60 skin sterol 60 proteasome inhibitor 60 Qdot 60 liposomal amphotericin B 60 serum biomarkers 60 F FDG PET 60 QUADRAMET R 60 polycythemia vera PV 60 GSTP1 60 protein biomarker 60 hc2 60 peptide conjugated 60 CCR5 receptor antagonist 60 vinorelbine tartrate 60 PEG SN# 60 ELISPOT assay 60 ELISA kit 60 ColonSentry ™ 60 radiotherapeutic 60 IMiDs ® compound 60 IV Busulfex 60 neratinib 60 Moxifloxacin 60 Estrogen Receptor 60 recombinant adeno associated 60 analyte specific 60 PROSTASCINT R 60 lymphoid tumors 60 Degarelix 60 specific antigen PSA 60 NOD mouse 60 PD2i ® 60 PET tracers 60 CINQUIL 60 druggable targets 60 fluoroquinolone antibiotic 60 Ag Ab Combo 60 Antigen CEA 60 vivo preclinical 60 proton MR spectroscopy 60 cardiac perfusion 60 serum biomarker 60 ARB telmisartan 60 Nexavar sorafenib tablets 60 Vascugel 60 GISTs 60 colon capsule endoscopy 60 molecular profiling 60 EBUS FNA 60 intranasal delivery 60 NB S# strontium malonate 60 NSABP B 60 thrombotic thrombocytopenic purpura TTP 60 BD GeneOhm 60 HERmark assay 60 prostate carcinomas 60 haplotyping 60 Sorafenib Nexavar 60 radionuclide therapy 60 Canvaxin TM 60 potent antiproliferative 60 NMR LipoProfile 60 Gamunex C 60 ResponseDX 60 PD LID 60 EGFR mutation 60 renal cell carcinomas 60 microsatellite instability 60 ALN TTR 60 immunostaining 60 GeneSearch 60 PLAC Test 60 oligonucleotide microarrays 60 RT PCR assay 60 AEG# 60 targeted antifolate 60 breast carcinomas 60 radioimmunotherapy RIT 60 transfection efficiency 60 NAVISTAR R 60 buffy coat 60 MYDICAR ® 60 bronchoalveolar lavage 60 Situ Hybridization FISH 60 methylated DNA 60 Traficet EN 60 Cardiotoxicity 60 OHR/AVR# 60 radiation sensitizer 60 Virtual Histology 60 Mutation Detection 60 CLIA certified laboratories 60 splice variants 60 syngeneic 60 Fludase 59 recombinant antibodies 59 massively parallel sequencing 59 diagnosing coronary artery 59 AQUA ® 59 PD2i 59 renal cortical 59 molecular biomarker 59 HepaSphere 59 ProstaScint 59 immunochemical fecal occult 59 Onalta 59 throughput RNAi 59 Angiolix 59 bortezomib Velcade 59 Transdrug ® nanoparticle 59 x ray angiography 59 Sequencing Systems 59 diagnostic assays 59 fidaxomicin Phase 59 anti CD3 59 Hurthle cell 59 Amrubicin 59 UPLYSO 59 radionuclide imaging 59 oral squamous cell 59 oral ridaforolimus 59 #F FDG PET 59 TAXUS Liberte Stent 59 antibody MAb 59 novel peptide 59 quantitative cytology 59 HLA typing 59 HuMax 59 Dalbavancin 59 XIENCE PRIME 59 humanized antibody 59 liposomal doxorubicin 59 rHuPH# recombinant human 59 treat chronic sinusitis 59 hypereosinophilic syndrome 59 magnetic resonance spectroscopy MRS 59 dasatinib Sprycel 59 Pemetrexed 59 LC MALDI 59 xMAP technology 59 methicillin resistance 59 randomized multicenter trial 59 product ColonSentry TM 59 PGxHealth FAMILION 59 interferon gamma 1b 59 Myocardial Perfusion Imaging 59 carcinoma HCC 59 ResponseDX Lung ™ 59 LC-MS/MS 59 Sentinel Lymph Node Biopsy 59 OVA1 ® 59 squamous miRview TM 59 Vidaza ® 59 vapreotide acetate 59 KRAS mutant 59 Outpatient Setting 59 HER2 positive cancers 59 pigmented skin lesions 59 SensoLyte ™ 59 AspirinWorks 59 metaplasia 59 A2 Lp PLA2 59 Cytoxan ® 59 NuroPro R 59 reslizumab 59 myeloproliferative 59 ceftazidime 59 Onalta ™ 59 nodal metastasis 59 bronchogenic carcinoma 59 histologies 59 iRICELL 59 Vicinium TM 59 miRNA assays 59 keratoplasty 59 cytologically confirmed 59 eTag assay 59 Monogram Trofile Assay 59 BRIM2 59 FOLOTYN ® 59 viral nucleic acids 59 Neuromodulation System 59 clinico pathological 59 bevacizumab Avastin ® 59 protease inhibitor PI 59 EmbraceAC 59 plasma kallikrein inhibitor 59 transthyretin amyloidosis 59 Biolimus A9 59 genomic biomarker 59 hemagglutination inhibition 59 TriGrid ™ 59 eligen R technology 59 careHPV 59 proprietary polysaccharide 59 novel oral anticoagulant 59 SPECT imaging 59 KRAS status 59 LUMINATE 59 sulindac 59 edifoligide 59 P2V TM 59 Renal Cell Carcinoma RCC 59 M2 subunit 59 Hemopurifier ® 59 Vidaza azacitidine 59 NicAlert 59 HBsAg 59 GRN# 59 AVI NEUGENE 59 TOF mass spectrometry 59 LTQ Orbitrap 59 transthoracic 59 Immunoassays 59 ultrasensitive detection 59 sentinel lymph nodes 59 PI3K/Akt pathway inhibitor 59 proteomic analysis 59 include ColorectAlert TM 59 Elvitegravir 59 quantitative PCR 59 HIF PH inhibitors 59 inhibitor RG# 59 Embozene TM Microspheres 59 pharmacogenetic testing 59 molecular subtypes 59 tumorigenicity 59 pharmacodynamic parameters 59 breast pancreatic 59 GV# [001] 59 E. faecalis 59 bowel capsule endoscopy 59 peritumoral brain edema 59 Umbilical cord stem cells 59 Luminex xMAP technology 59 GRNCM1 59 Circulating Tumor Cells 59 PCA3 test 59 induced macular edema 59 pertuzumab 59 BiTE 59 phase IIb clinical 59 SCIg 59 p# antigen 59 ELISPOT 59 Magnetic resonance 59 BRACAnalysis 59 Assay Kits 59 squamous cell lung cancer 59 Epirubicin 59 Systemic Delivery 59 TH# [003] 59 mutated K ras 59 Liver biopsies 59 BC SeraPro ™ 59 gene amplification 59 CyPath ® assay 59 quantitate 59 androgen receptor antagonist 59 VerifyNow System 59 RECAF tm 59 Spectral EAA TM 59 malignant lesions 59 miRNA molecules 59 GW# [003] 59 ovarian breast 59 discontinued Viread 59 subependymal giant cell 59 Peptidomics 59 MedPulser 59 MORAb 59 CupPrint 59 etanercept Enbrel 59 K ras 59 Procleix 59 cardiac channelopathies 59 HER2 gene 59 Trofile 59 Xpert MTB RIF 59 ADVEXIN therapy 59 advanced metastatic renal 59 PROCHYMAL 59 Quantitative PCR 59 oral prodrug 59 INTERCEPT platelets 59 prognostic markers 59 Nexavar ® 59 CCR5 antagonist 59 monoclonal antibody mAb 59 metastatic lymph nodes 59 visit www.dobimedical.com 59 HCV RESPOND 2 59 cyclophilin inhibitors 59 meropenem 59 external counterpulsation systems 59 MiCK assay 59 superficial bladder cancer 59 thalidomide Thalomid 59 NADiA ProsVue 59 PD2i R 59 Platinol ® cisplatin 59 PhG alpha 1 59 EP #R 59 SNP Array #.# 59 PNA FISH TM 59 malignant pleural mesothelioma 59 genomic proteomic 59 interferon lambda 59 cytolytic activity 59 Neo Bladder Augment 59 toxigenic Clostridium difficile 59 EGFR TKIs 59 TPMT 59 variant allele 59 predictive biomarker 59 hyaluronidase enzyme 59 YONDELIS R 59 GenWay Biotech 59 Arikace 59 Tarvacin 59 proprietary BiTE ® 59 CaPSURE 59 Prodrug TAP technology 59 Pyridorin 59 Kahalalide F 59 intranasal formulation 59 MyoCell TM 59 IMA# 59 Intravenous immunoglobulin 59 PCR primers 59 pegylated alpha interferon 59 TLR8 agonist 59 Vitro Diagnostic IVD 59 LNP formulations 59 HBV vaccine 59 tissue microarray 59 Multivariate logistic regression 59 OmniWave 59 potent topoisomerase II 59 annexin V 59 serum protein biomarkers 59 palliative radiotherapy 59 NeuroStar TMS Therapy 59 Bafetinib 59 serologic 59 TaqMan ® 59 OVA1 Test 59 TG# [003] 59 PROCRIT R 59 e2 Collector 59 prostate cancer PCa 59 pharmacodynamic effects 59 SpectraCell 59 rNAPc2 59 SNP Genotyping 59 PORxin TM 59 non nucleoside 59 molecular assays 59 vorinostat 59 FFPE 59 Velcade bortezomib 59 pharmacokinetic PK study 59 HybSelect 59 immunomodulatory properties 59 Oncotype DX TM 59 ALTROPANE 59 bronchial hyperresponsiveness 59 FLT3 59 demonstrated antitumor activity 59 deCODE BreastCancer TM 59 automated immunoassay 59 ANG# 59 PRTX 59 PreGen Plus TM 59 biochemical profiling 59 Allogeneic 59 upper endoscopy 59 ResponseDX Colon ™ 59 topically administered 59 rhBMP 2 59 serum antibody 59 artery embolization 59 Enzastaurin 59 prognostic marker 59 Oral Mucositis 59 MTT assay 59 Nektar proprietary 59 hPTH #-# 59 GeneChip R 59 CCR5 inhibitor 59 nonlinear algorithm 59 optical biosensors 59 Upregulation 59 ImmunoCAP ® 59 BCIRG 59 EBUS 59 imatinib Gleevec 59 BARACLUDE R 59 Quantitation 59 angiographically 59 Allovectin 7 ® 59 Sanger Sequencing 59 QRT PCR 59 prognostic indicator 59 S. aureus isolates 59 Nilotinib 59 Quinamed 59 DNA intercalator 59 treat benign prostatic 59 mammographically 59 urothelial cancer 59 cytologic 59 Aurexis 59 HER2 receptor 59 AAV vector 59 everolimus eluting stent 59 RRM1 59 pharmacodynamic properties 59 virus AAV 58 novel VDA molecule 58 PCR Polymerase Chain Reaction 58 Affibody 58 SNP genotyping 58 Pathway Inhibitor 58 clade B